|1.||Zhao, Yong: 4 articles (07/2015 - 05/2005)|
|2.||Su, Jiankun: 3 articles (05/2014 - 01/2013)|
|3.||Gao, Xiaoyan: 3 articles (05/2014 - 01/2013)|
|4.||Zhang, Li: 3 articles (05/2014 - 01/2013)|
|5.||Liu, Haiyu: 3 articles (05/2014 - 01/2013)|
|6.||Guo, Mingxing: 3 articles (05/2014 - 01/2013)|
|7.||Peng, Long: 3 articles (05/2014 - 01/2013)|
|8.||Yi, Yan: 2 articles (07/2015 - 06/2009)|
|9.||Wang, Qingguo: 2 articles (01/2012 - 03/2006)|
|10.||Xiao, Ying: 2 articles (09/2011 - 05/2011)|
11/01/2005 - "To discuss the efficacy of Qingkailing soft capsules in treating acute fever, and the relationship between symptoms-effect and time effect. "
01/01/2013 - "UPLC Q-TOF/MS-Based Metabolic Profiling of Urine Reveals the Novel Antipyretic Mechanisms of Qingkailing Injection in a Rat Model of Yeast-Induced Pyrexia."
01/01/2014 - "Qingkailing injection (QKLI), a modern traditional Chinese medicine preparation, has been widely used in clinics due to its fast and significant efficacy in treatment of high fever. "
02/01/2009 - "[Effects of Qingkailing effective components on nuclear factor-kappa B in an ischemia-reperfusion injury model of rat brain microvascular endothelial cells in vitro]."
02/01/2009 - "To establish an ischemia-reperfusion injury model of rat cerebral microvascular endothelial cells (MVECs) in vitro, and to explore the relationship between nuclear factor-kappa B (NF-kappaB) and the protective effects of Qingkailing effective components (hyocholic acid, taurocholic acid, baicalin, jasminoidin, Pinctada martensii) on MVECs. "
12/01/2012 - "The ratio between the serious ADR of proprietary Chinese medicines and the safety risk of non-proprietary Chinese medicines was 1.057 (95% CI:0.915, 1. 221), suggesting that the safety of proprietary Chinese medicines was not higher than the non-proprietary Chinese; as such medicines as Qingkailing, Xuesaitong and Xiangdan have ranked top five for years in terms of ADR and serious ADR, the drug administration and hygiene system shall take more effective control measures for strengthening the monitoring over rational use of drugs; clinical manifestations of severe ADR of proprietary Chinese medicines were dominated by allergic shock, which could not be effectively prevented and monitored by such means as skin test, therefore, pre-clinical treatment risk-benefit evaluation shall be improved."
|4.||Anaphylaxis (Anaphylactic Shock)
09/01/2015 - "The study aims to quantify anaphylaxis signal for combined exposure of benzylpenicilin and qingkailing injection (QI) compared with individual exposure of the two drugs and the background risk based on all other exposures in SRS database. "
12/01/2012 - "To study the anaphylaxis of Qingkailing injection (QI) and its components. "
12/01/2012 - "Experimental study on anaphylaxis of qingkailing injection and its components on Beagle dogs."
09/01/2011 - "[Correlation between change of immunotoxicology indexes of cerum and the occurrence of anaphylaxis in patients induced by qingkailing injection: a clinical study]."
05/01/2011 - "To determine the relation between the change of immunology indexes of serum and the occurrence of anaphylaxis in patients induced by Qingkailing injection, and to establish the method of detection of the type of anaphylaxis in patients induced by traditional Chinese medicine (TCM) injection. "
04/01/2014 - "To evaluate systematically the clinical efficacy and safety of Qingkailing (QKL) injection in the treatment of acute stroke. "
04/01/2014 - "Qingkailing injection for the treatment of acute stroke: a systematic review and meta-analysis."
01/01/2012 - "Chinese medicine injection qingkailing for treatment of acute ischemia stroke: a systematic review of randomized controlled trials."
|3.||NF-kappa B (NF-kB)
|4.||Taurocholic Acid (Sodium Taurocholate)
|10.||Oleic Acid (Oleate)
|1.||Chinese Traditional Medicine (Traditional Chinese Medicine)